Beijing Chunlizhengda Medical Instruments Co., Ltd. commences an Equity Buyback Plan for 9,585,200 H shares, representing 10% of its issued share capital, under the authorization approved on June 1, 2022.

Beijing Chunlizhengda Medical Instruments Co., Ltd. (SEHK:1858) commences share repurchases on September 16, 2022, under the program mandated by the shareholders in the Annual General Meeting held on June 1, 2022. As per the mandate, the company is authorized to repurchase 9,585,200 H shares, representing up to 10% of the issued share capital. The repurchases will lead to an enhancement of the net asset value per share and/or earnings per share for the company.

The repurchases will be made out of the funds legally available for such purpose in accordance with its memorandum of association and Bye-laws and the applicable laws and regulations of the PRC. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of June 1, 2022, the company had 95,852,000 H shares in issue.